Literature DB >> 11957555

Influenza in Singapore: assessing the burden of illness in the community.

T P Ng1, K H Pwee, M Niti, L G Goh.   

Abstract

INTRODUCTION: Influenza infection has significant morbidity and mortality. The social and economic costs from work absence in the working population and from hospitalisations in the elderly are considerable. Meta-analyses of cohort and randomised controlled studies indicate that influenza vaccination is effective in preventing respiratory illness, hospitalization, pneumonia and death in 50% to 68% of cases. In Singapore, data on the disease burden from influenza are sparse and no official recommendation on influenza vaccination exists.
METHOD: We estimated the disease burden of influenza-like illness (ILI), influenza infection in the general adult population, and hospitalisations and deaths from pneumonia and influenza, from routine official and published sources, and hoc community sample surveys, national virological surveillance, hospitalization and mortality data.
RESULTS: In a resident population of 3 million people, there were 4.2 million cases of ILI in a typical non-epidemic year, 3.5 million visits to the doctor and 2.1 million days of work absence due to ILI. Data from the National Influenza Surveillance Programme indicated that about 15% of patients with ILI were positive for influenza isolates. We therefore estimated 630,000 cases of influenza virus infection cases a year, giving rise to 520,000 sick visits and 315,000 days of sick absence from work. About 4200 elderly (65+) persons were hospitalised for pneumonia and influenza, resulting in about 1450 deaths every year. The literature suggests a vaccine efficacy of about 50% of preventing influenza and its complications, including hospitalizations and deaths. This indicates that at least 315,000 cases of influenza virus infection, 258,000 sick visits, and 157,000 lost days from work in the whole population, and 2100 hospitalisations and 600 deaths from pneumonia in the elderly are potentially preventable by vaccination each year.
CONCLUSION: Influenza poses a considerable burden of illness in the community and the potential benefits from influenza vaccination are substantial.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11957555

Source DB:  PubMed          Journal:  Ann Acad Med Singapore        ISSN: 0304-4602            Impact factor:   2.473


  24 in total

1.  Incidence of influenza-like illness and severe acute respiratory infection during three influenza seasons in Bangladesh, 2008-2010.

Authors:  Eduardo Azziz-Baumgartner; A S M Alamgir; Mustafizur Rahman; Nusrat Homaira; Badrul Munir Sohel; M A Yushuf Sharker; Rashid Uz Zaman; Jacob Dee; Emily S Gurley; Abdullah Al Mamun; Syeda Mah-E-Muneer; Alicia M Fry; Marc-Alain Widdowson; Joseph Bresee; Stephen Lindstrom; Tasnim Azim; Abdullah Brooks; Goutam Podder; M Jahangir Hossain; Mahmudur Rahman; Stephen P Luby
Journal:  Bull World Health Organ       Date:  2011-10-04       Impact factor: 9.408

2.  Trends of out-of-pocket expenditure for influenza in China Health and Nutrition Survey during 1989-2006.

Authors:  Jinan Liu; Lizheng Shi; Mahmud Khan; Lingzhong Xu; Liya Wang
Journal:  Int J Public Health       Date:  2011-04-19       Impact factor: 3.380

Review 3.  The impact of influenza on working days lost: a review of the literature.

Authors:  Martin Keech; Paul Beardsworth
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

4.  Economic analysis of pandemic influenza vaccination strategies in Singapore.

Authors:  Vernon J Lee; Mei Yin Tok; Vincent T Chow; Kai Hong Phua; Eng Eong Ooi; Paul A Tambyah; Mark I Chen
Journal:  PLoS One       Date:  2009-09-22       Impact factor: 3.240

Review 5.  Oseltamivir in seasonal influenza: cumulative experience in low- and high-risk patients.

Authors:  Regina Dutkowski
Journal:  J Antimicrob Chemother       Date:  2010-04       Impact factor: 5.790

Review 6.  Reducing the burden of influenza-associated complications with antiviral therapy.

Authors:  B R Ruf; T Szucs
Journal:  Infection       Date:  2009-05-26       Impact factor: 3.553

7.  Incidence, seasonality and mortality associated with influenza pneumonia in Thailand: 2005-2008.

Authors:  James Mark Simmerman; Malinee Chittaganpitch; Jens Levy; Somrak Chantra; Susan Maloney; Timothy Uyeki; Peera Areerat; Somsak Thamthitiwat; Sonja J Olsen; Alicia Fry; Kumnuan Ungchusak; Henry C Baggett; Supamit Chunsuttiwat
Journal:  PLoS One       Date:  2009-11-11       Impact factor: 3.240

8.  Influenza pandemics in Singapore, a tropical, globally connected city.

Authors:  Vernon J Lee; Mark I Chen; Slew Pang Chan; Chia Siong Wong; Jeffery Cutter; Kee Tai Goh; Paul Anath Tambyah
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

9.  Influenza-associated deaths in tropical Singapore.

Authors:  Angela Chow; Stefan Ma; Ai Ee Ling; Suok Kai Chew
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

10.  Economics of neuraminidase inhibitor stock piling for pandemic influenza, Singapore.

Authors:  Vernon J Lee; Kai Hong Phua; Mark I Chenm; Angela Chow; Stefan Ma; Kee Tai Goh; Yee Sin Leo
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.